Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
- Authors
- Chowdhury, Sumaiya; Chen, Yiqian; Yao, Tsun-Wen; Ajami, Katerina; Wang, Xin M; Popov, Yury; Schuppan, Detlef; Bertolino, Patrick; McCaughan, Geoffrey W; Yu, Denise Mt; Gorrell, Mark D
- Year
- 2013
- Journal
- World journal of gastroenterology
- PMID
- 23704821
- DOI
- 10.3748/wjg.v19.i19.2883
- PMCID
- PMC3660813
AIM: To investigate the expression of dipeptidyl peptidase (DPP) 8 and DPP9 in lymphocytes and various models of liver fibrosis. METHODS: DPP8 and DPP9 expression were measured in mouse splenic CD4⁺ T-cells, CD8⁺ T-cells and B-cells (B220⁺), human lymphoma cell lines and mouse splenocytes stimulated with pokeweed mitogen (PWM) or lipopolysaccharide (LPS), and in dithiothreitol (DTT) and mitomycin-C treated Raji cells. DPP8 and DPP9 expression were measured in epidermal growth factor (EGF) treated Huh7 hepatoma cells, in fibrotic liver samples from mice treated with carbon tetrachloride (CCl₄) and from multidrug resistance gene 2 (Mdr2/Abcb4) gene knockout (gko) mice with biliary fibrosis, and in human end stage primary biliary cirrhosis (PBC). RESULTS: All three lymphocyte subsets expressed DPP8 and DPP9 mRNA. DPP8 and DPP9 expression were upregulated in both PWM and LPS stimulated mouse splenocytes and in both Jurkat T- and Raji B-cell lines. DPP8 and DPP9 were downregulated in DTT treated and upregulated in mitomycin-C treated Raji cells. DPP9-transfected Raji cells exhibited more annexin V⁺ cells and associated apoptosis. DPP8 and DPP9 mRNA were upregulated in CCl₄ induced fibrotic livers but not in the lymphocytes isolated from such livers, while DPP9 was upregulated in EGF stimulated Huh7 cells. In contrast, intrahepatic DPP8 and DPP9 mRNA expression levels were low in the Mdr2 gko mouse and in human PBC compared to non-diseased livers. CONCLUSION: These expression patterns point to biological roles for DPP8 and DPP9 in lymphocyte activation and apoptosis and in hepatocytes during liver disease pathogenesis.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci. | 2014 | 24166409 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A fluorescent sensor for real-time monitoring of DPP8/9 reveals crucial roles in immunity and cancer. | Weiss K et al. | — | 2025 | → |
| Dipeptidyl peptidase 9 (DPP9) depletion from hepatocytes in experimental primary liver cancer. | Huang JC et al. | — | 2025 | → |
| Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase-1- and Gasdermin-Dependent Cell Death. | De Loose J et al. | — | 2025 | → |
| Identifying potential drug targets for cerebral amyloid angiopathy: A Mendelian randomization study based on the druggable genes. | Zhang J et al. | — | 2025 | → |
| Study on the correlation between <i>DPP9</i> rs2109069 and <i>IFNAR2</i> rs2236757 polymorphisms with COVID-19 mortality. | Safari M et al. | — | 2025 | → |
| Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysin. | Ahmad SS et al. | — | 2025 | → |
| The multifunctional regulatory post-proline protease dipeptidyl peptidase 9 and its inhibitors: new opportunities for therapeutics. | Nguyen JMH et al. | — | 2025 | → |
| DPP9 regulates NQO1 and ROS to promote resistance to chemotherapy in liver cancer cells. | Zhou Y et al. | — | 2024 | → |
| Dipeptidyl-Aminopeptidases 8 and 9 Regulate Autophagy and Tamoxifen Response in Breast Cancer Cells. | Bettecken A et al. | — | 2023 | → |
| CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender. | Sharif-Zak M et al. | — | 2022 | → |
| New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors. | Cui C et al. | — | 2022 | → |
| Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity. | Posadas-Sánchez R et al. | — | 2021 | → |
| Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular Carcinoma. | Henderson JM et al. | — | 2021 | → |
| DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma. | Huang JC et al. | — | 2021 | → |
| Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells. | Zhang Y et al. | — | 2021 | → |
| Human proline specific peptidases: A comprehensive analysis. | Dunaevsky YE et al. | — | 2020 | → |
| CD26/DPP4 - a potential biomarker and target for cancer therapy. | Enz N et al. | — | 2019 | → |
| Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics. | Zhang HE et al. | — | 2019 | → |
| Immune regeneration in irradiated mice is not impaired by the absence of DPP9 enzymatic activity. | Gall MG et al. | — | 2019 | → |
| Fibroblast activation protein enzyme deficiency prevents liver steatosis, insulin resistance and glucose intolerance and increases fibroblast growth factor-21 in diet induced obese mice | Chowdhury S et al. | — | 2018 | — |
| Dipeptidyl peptidase 9 (DPP9) in human skin cells. | Gabrilovac J et al. | — | 2017 | → |
| Expression, subcellular localisation, and possible roles of dipeptidyl peptidase 9 (DPP9) in murine macrophages. | Zapletal E et al. | — | 2017 | → |
| Fibroblast activation protein is dispensable in the anti-influenza immune response in mice. | Tan SY et al. | — | 2017 | → |
| Hepatocellular carcinoma: Mouse models and the potential roles of proteases. | Henderson JM et al. | — | 2017 | → |
| The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury. | Wang XM et al. | — | 2017 | → |
| Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes. | Chen Y et al. | — | 2016 | → |
| The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice. | Waumans Y et al. | — | 2016 | → |
| Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin. | Zhang H et al. | — | 2015 | → |
| The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis. | Waumans Y et al. | — | 2015 | → |
| A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation. | Osborne B et al. | — | 2014 | → |
| Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci. | Gelernter J et al. | — | 2014 | → |
| Vildagliptin , a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin. | Forst T et al. | — | 2014 | → |
| Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9. | Zhang H et al. | — | 2013 | → |
| DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues. | Harstad EB et al. | — | 2013 | → |
| KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. | Moody R et al. | — | 2013 | → |
| Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. | Keane FM et al. | — | 2013 | → |
| Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality. | Gall MG et al. | — | 2013 | → |